MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-09-2026
Myomo DSO Ratio 2011-2026 | MYO
Annual DSO Ratio Myomo
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.3 | - | 0.704 | 38 | 44.5 | 40.4 | 57.1 | 69.6 | - | 61.2 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 69.6 | 0.704 | 43.3 |
Quarterly DSO Ratio Myomo
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.8 | 55.4 | 39.4 | - | 31 | 25.5 | 49.4 | - | 37.4 | 24.4 | 45.6 | - | 18.3 | 21 | 43.1 | - | 34.8 | 27.9 | 33 | - | 43.8 | 98.3 | 61.1 | - | 63.8 | 44 | 44.3 | - | 57.3 | 55.2 | 99 | - | 55.5 | 88.4 | 86.8 | - | 56.7 | 20.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 99 | 18.3 | 48.9 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Insulet Corporation
PODD
|
40.7 | $ 216.0 | -4.21 % | $ 15.2 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Quanterix Corporation
QTRX
|
81.6 | $ 3.96 | 3.66 % | $ 169 M | USA |
 |
AVITA Medical
RCEL
|
53.2 | $ 3.99 | 3.91 % | $ 111 M |  Australia |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
45.6 | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
IRadimed Corporation
IRMD
|
52.7 | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
67 | $ 2.56 | -0.39 % | $ 7.1 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Sensus Healthcare
SRTS
|
171 | $ 4.22 | 6.57 % | $ 68.9 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
29.7 | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
137 | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
Tactile Systems Technology
TCMD
|
49.2 | $ 26.96 | 0.37 % | $ 617 M | USA |
 |
TELA Bio
TELA
|
51.1 | $ 0.69 | -9.35 % | $ 15.8 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Tandem Diabetes Care
TNDM
|
176 | $ 24.26 | -1.02 % | $ 1.65 B | USA |
 |
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.67 | -3.52 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
40.7 | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
76 | $ 1.77 | -1.12 % | $ 114 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
46.5 | $ 336.27 | 0.63 % | $ 13.1 B | USA |
 |
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Outset Medical
OM
|
97.7 | $ 3.53 | - | $ 53.7 K | USA |
 |
Inspire Medical Systems
INSP
|
42.6 | $ 51.41 | -1.27 % | $ 1.51 B | USA |
 |
Varex Imaging Corporation
VREX
|
67.9 | $ 10.69 | 0.66 % | $ 443 M | USA |